BiotechTube
Home/Vaxxas/Sarah Meibusch
SM

Sarah Meibusch

Board Chair

Vaxxas

Therapeutic Areas

Infectious DiseaseOncology

Vaxxas Pipeline

DrugIndicationPhase
HD-MAP Influenza VaccineInfluenza PreventionPhase 2/3
Platform Partnerships (e.g., with Merck)Various Infectious DiseasesPre-clinical/Phase 1

Leadership Team at Vaxxas

DP
David Peacock
Chief Executive Officer
AF
Angus Forster, Ph.D.
Chief Technology Officer
SF
Scott Fry, Ph.D.
Chief Operating Officer
TL
Tom Lake
Chief Business Officer
View full Vaxxas profile